Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

IBM Ventures

Investor type Corporate Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 16
Average round size
The average size of a deal this fund participated in
Portfolio companies 16
Rounds per year 0.76
Lead investments 1
Exits 3
Key employees 3

Areas of investment

  • Software
  • Information Technology
  • Enterprise Software
  • Health Care
  • Information Services

IBM Ventures appeared to be the VC, which was created in 2001. The fund was located in North America if to be more exact in United States. IBM Ventures seemed to be an CVC arrangement as part of the organization. The main department of described VC is located in the San Francisco.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Welltok, IFTTT, WayBlazer For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular fund investment industries, there are Software, Health Care.

We also calculated 3 valuable employees in our database.

When the investment is from IBM Ventures the average startup value is 10-50 millions dollars. The important activity for fund was in 2015. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year. This IBM Ventures works on 7 percentage points less the average amount of lead investments comparing to the other organizations.

The typical case for the fund is to invest in rounds with 5 participants. Despite the IBM Ventures, startups are often financed by ICONIQ Capital, TriZetto, Salesforce Ventures. The meaningful sponsors for the fund in investment in the same round are IBM, Salesforce Ventures, Yahoo. In the next rounds fund is usually obtained by Norwest Venture Partners, Microsoft, USAA.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of IBM Ventures:
Typical Co-investors
IBM Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after IBM Ventures:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Additio Investment Group Barcelona, Catalonia, Spain
Asia Pacific Land China, Hong Kong, Hong Kong Island
B37 Ventures California, San Francisco, United States
Conservation International Ventures Arlington, United States, Virginia
EXF Alpha -
Hsin Investments -
Jackson Square Ventures California, San Francisco, United States
Market One Capital Luxembourg, Luxembourg
Mogao Venture Capital China, Guangdong, Shenzhen
Oplink Communications LLC California, Fremont, United States
The Boston Foundation Boston, Massachusetts, United States
Tokalon Ventures New York, New York, United States
U.S. Department of Energy Solar Energy Technologies Office Seattle, United States, Washington
Vedere Ventures -
Whitebox Advisors Minneapolis, Minnesota, United States
York IE Manchester, New Hampshire, United States
Yum! Brands Kentucky, Louisville, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Network Security
12 Oct 2022 Tel Aviv-Yafo, Tel Aviv District, Israel


Big Data
Cloud Data Services
Enterprise Software
$116M12 Jul 2022 San Francisco, California, United States


Information Services
Information Technology
$25M22 Feb 2022 Charlotte, North Carolina, United States


Health Care
$10M11 Jan 2022 New York, New York, United States


Developer Platform
Developer Tools
IT Management
$140M13 Sep 2021 Chicago, Illinois, United States


Health Care
Health Diagnostics
Information Technology
Life Science
Personal Health
$20M15 Mar 2021 Framingham, Massachusetts, United States

Cambridge Quantum Computing

Artificial Intelligence
Enterprise Software
Quantum Computing
$45M08 Dec 2020 England


Information Services
Information Technology
$24M26 Apr 2018 San Francisco, California, United States


Enterprise Software
Information Technology
$55M13 Sep 2017 California, United States
Copado Raises $140 Million Series C Round to Expand Its DevOps Platform Across Leading Enterprise SaaS Clouds, Approaches $1.2 Billion Valuation

– Copado has raised $140m in Series C financing.
– The round was led by Insight Partners and includes participation from new investors SoftBank Vision Fund 2, Declaration Partners and DG Ventures, as well as existing investors Salesforce Ventures, ISAI Cap Venture, Lead Edge Capital, and Perpetual Investors. Strategic investor IBM Ventures also participated in the round.
– Proceeds will be used to expand its DevOps and AI-enabled testing solutions across the leading enterprise SaaS platforms driving today’s digital transformation projects.

Variantyx Secures $20M in Series C Funding

– Variantyx, a Boston, MA-based hereditary disease testing company, secured $20M in Series C funding.
– The round was led by GHS Fund (Quark Venture LP and GF Securities) and includes new investor, IBM Ventures and current investors, Pitango Venture Capital, New Era Capital Partners, 20/20 HealthCare Partners.
– In conjunction with the funding, Zafrira Avnur, PhD, Quark Venture Chief Scientific Officer & Partner, will join the Variantyx board of directors.
– The company intends to use the funds for development of its tumor diagnostic solutions and the expansion of sales.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent IBM Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: